Clinical Trial

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The design of this study is an intervention, randomized, controlled study and contains three randomized groups:(1)PVI group;(2)PVI+PWI group;(3)PVI+PWI+EGM group.
Trial Details
NCT Number NCT07122336
Lead Sponsor Shanghai Chest Hospital
Conditions Persistent Atrial Fibrillation
Enrollment 384 participants
Start Date 2025-07-16
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-14